טוען...
Biology, Pathology, and Therapeutic Targeting of RAS
RAS was identified as a human oncogene in the early 1980’s and found to be mutated in nearly 30% of all human cancers. More importantly, however, RAS plays a central role in driving tumor development and maintenance. Despite decades of effort, there remain no FDA approved drugs that directly inhibit...
שמור ב:
| הוצא לאור ב: | Adv Cancer Res |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7393484/ https://ncbi.nlm.nih.gov/pubmed/32723567 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/bs.acr.2020.05.002 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|